share_log

博拓生物(688767.SH):新冠相关资产已在2023年度完成计提减值准备

Botuo Biotech (688767.SH): COVID-19 related assets have been prepared for depreciation in 2023

Gelonghui Finance ·  May 13 16:13

Gelonghui, May 13 | Botuo Biotech (688767.SH) recently said during a survey reception from institutional investors that the total asset impairment losses calculated by the company in 2023 were 588.364 million yuan, mainly inventory impairment losses, with a small portion being credit impairment losses. COVID-19 related assets have been prepared for depreciation in 2023 and will not have an impact on subsequent reporting periods.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment